^○乾 直輝¹, 菅原 俊一², 樋田 豊明³, 吉田 達哉⁴, 田中 洋史⁵, 熊谷 融⁶, 加藤 晃史⁷, 寺岡 俊輔⁸, 岡本 勇⁹, 細見 幸生¹⁰, 福原 達朗¹¹, 仲 剛¹², 関 順彦¹³, 西尾 誠人¹⁴, 大江 裕一郎⁴, 田村 友秀¹⁵, 山本 信之⁸, 赤松 弘朗⁸, 高橋 滋¹⁶, 中川 和彦¹⁷ (1.浜松医科大学医学部附属病院 呼吸器内科, 2.仙台厚生病院 呼吸器内科, 3.愛知県がんセンター 呼吸器内科, 4.国立がん研究センター中央病院 呼吸器内科, 5.新潟県立がんセンター新潟病院 内科, 6.大阪国際がんセンター 呼吸器内科, 7.神奈川県立がんセンター 呼吸器内科, 8.和歌山県立医科大学 内科学第三講座, 9.九州大学病院 呼吸器科, 10.がん・感染症センター都立駒込病院 呼吸器内科, 11.宮城県立がんセンター 呼吸器内科, 12.国立国際医療研究センター病院 呼吸器内科, 13.帝京大学医学部 内科学講座 腫瘍内科, 14.がん研究会有明病院 呼吸器内科, 15.聖路加国際病院 呼吸器センター, 16.小野薬品工業株式会社 オンコロジー臨床開発企画部第1室, 17.近畿大学医学部 内科学腫瘍内科部門)

^○齋藤 春洋¹, Johnson Melissa L², Cho Byoung Chul³, Luft Alexander⁴, Alatorre-Alexander Jorge A.⁵, Geater Sarayut Lucien⁶, Laktionov Konstantin⁷, Vasiliev Aleksandr⁸, Trukhin Dmytro⁹, Kim Sang-We¹⁰, Ursol Grygorii¹¹, Hussein Maen¹², Lim Farah Louise¹³, Yang Cheng-Ta¹⁴, Araujo Luiz Henrique¹⁵, Reinmuth Niels¹⁶, Shi Xiaojin¹⁷, Poole Lynne¹⁸, Peters Solange¹⁹, Garon Edward B.²⁰, Mok Tony²¹ (1.神奈川県立がんセンター, 2.Sarah Cannon Research Institute, Tennessee Oncology, PLLCC, Nashville, TN, USA, 3.Yonsei Cancer Center, Seoul, Korea, 4.Leningrad Regional Clinical Hospital, St Petersburg, Russia, 5.Health Pharma Professional Research, Mexico City, Mexico, 6.Prince of Songkla University, Songkhla, Thailand, 7.Federal State Budgetary Institution “N.N. Blokhin National Medical Research Center of Oncology” of the Ministry of Health of the Russian Federation (N.N. Blokhin NMRCO), Moscow, Russia, 8.“Private Health Institution “Clinical Hospital” RZD-Medicine”, St Petersburg, Russia, 9.Odessa Regional Oncological Dispensary, Odessa, Ukraine, 10.Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea, 11.Acinus, Kropyvnytskyi, Ukraine, 12.Florida Cancer Specialists – Sarah Cannon Research Institute, Leesburg, FL, USA, 13.Queen Mary University of London, London, United Kingdom, 14.Chang Gung Memorial Hospital, Taoyuan City, Taiwan, 15.Instituto Nacional de Cancer-INCA, Rio de Janeiro, Brazil, 16.Asklepios Lung Clinic, Munich-Gauting, Germany, 17.AstraZeneca, Gaithersburg, MD, USA, 18.AstraZeneca, Cambridge, UK, 19.Centre Hospitalier Universitaire Vaudois, Lausanne University, Lausanne, Switzerland, 20.David Geffen School of Medicine at UCLA, Los Angeles, CA, USA, 21.Chinese University of Hong Kong, Hong Kong, China)

^○Takayasu Kurata¹, James Chih-Hsin Yang², Isamu Okamoto³, Li Zhang⁴, Jie Hu⁵, Donglin Wang⁶, Chengping Hu⁷, Jianying Zhou⁸, Lin Wu⁹, Lejie Cao¹⁰, Jiwei Liu¹¹, Helong Zhang¹², Hong Sun¹³, Ziping Wang¹⁴, Hongjun Gao¹⁵, Yan Yan¹⁶, Suijun Xiao¹⁶, Jianxin Lin¹⁷, M. Catherine Pietanza¹⁷, Ying Cheng¹⁸ (1.Department of Thoracic Oncology, Kansai Medical University Hospital, Osaka, Japan, 2.Department of Oncology, National Taiwan University Hospital and National Taiwan University Cancer Center, Taipei, Republic of China, 3.Kyushu University Hospital, Fukuoka, Japan, 4.Respiratory Medicine Department, Peking Union Medical College Hospital, Beijing, China, 5.Department of Pulmonary Medicine, Zhongshan Hospital Fudan University, Shanghai, China, 6.Department of Oncology, Chongqing Cancer Hospital, Chongqing, China, 7.Department of Respirology and Critical Care Medicine, Xiangya Hospital Central South University, Changsha, China, 8.Department of Respiratory Diseases, The First Affiliated Hospital of Zhejiang University, Hangzhou, China, 9.Department of Thoracic Medicine, Hunan Cancer Hospital, Changsha, China, 10.Department of Respiration, The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital), Hefei, China, 11.Department of Oncology, The First Affiliated Hospital of Dalian Medical University, Dalian, China, 12.Department of Oncology, Tang Du Hospital, The Fourth Military Medical University, Xi'an, China, 13.Department of Oncology, The First Affiliated Hospital of Xi’An Jiaotong University, Xi'an, China, 14.Department of Thoracic Medical Oncology, Beijing Cancer Hospital, Beijing, China, 15.Department of Pulmonary Oncology, Affiliated Hospital of Academy of Military Medical Sciences, Beijing, China, 16.MSD, Shanghai, China, 17.Merck & Co., Inc., Kenilworth, NJ, USA, 18.Department of Medical Oncology, Jilin Cancer Hospital, Chaoyang Borough, Changchun, China)

^○Kaoru Kubota¹, Byoung Chul Cho², Vichien Srimuninnimit³, Yu Fan⁴, Jianying Zhou⁵, Li Zhang⁶, Qing Zhou^7,8, Yukio Hosomi⁹, Hiroaki Takeoka¹⁰, Rinee Mukherjee¹¹, Wei Fu¹¹, Fabricio Souza¹¹, Tony S. K. Mok¹², Li Zhang¹³ (1.Department of Pulmonary Medicine and Oncology, Nippon Medical School Hospital, Tokyo, Japan, 2.Division of Medical Oncology, Yonsei Cancer Center, Seoul, South Korea, 3.Department of Medicine, Siriraj Hospital, Bangkok, Thailand, 4.Thoracic Medical Oncology Department of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, China, 5.Department of Respiratory Diseases, The First Affiliated Hospital of Zhejiang University, Hangzhou, China, 6.Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China, 7.Guangdong Provincial Key Laboratory of Translational Medicine in Lung Cancer, Guangdong Lung Cancer Institute, Guangzhou, China, 8.Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, Guangzhou, China, 9.Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan, 10.Department of Respiratory Medicine, Clinical Research Institute, National Hospital Organization, Kyushu Medical Center, Fukuoka, Japan, 11.Merck & Co., Inc., Kenilworth, NJ, USA, 12.Clinical Oncology, State Key Laboratory of Translational Oncology, Chinese University of Hong Kong, Shatin, Hong Kong, China, 13.Peking Union Medical College Hospital, Beijing, China)

^○藤本 伸一¹, Solange Peters², Arnaud Scherpereel³, Robin Cornelissen⁴, Youssef Oulkhouir⁵, Laurent Greillier⁶, Muhammet Ali Kaplan⁷, Toby Talbot⁸, Isabelle Monnet⁹, Sandrine Hiret¹⁰, Paul Baas¹¹, Anna K. Nowak¹², Anne S. Tsao¹³, Aaron S. Mansfield¹⁴, Sanjay Popat¹⁵, Xiaoqing Zhang¹⁶, Nan Hu¹⁶, David Balli¹⁶, Jenine Sanzari¹⁶, Gerard Zalcman¹⁷ (1.岡山労災病院, 2.Lausanne University Hospital, Lausanne, Switzerland, 3.University of Lille, CHU Lille, INSERM, OncoThAI, Lille, France, 4.Erasmus MC Cancer Institute, Rotterdam, Netherlands, 5.Hôpital Côte de Nacre CHU Caen, Caen, France, 6.Aix Marseille University, APHM, INSERM, CNRS, CRCM, Hôpital Nord, Marseille, France, 7.Dicle University, Diyarbakir, Turkey, 8.Royal Cornwall Hospitals NHS Trust, Truro, UK, 9.Centre Hospitalier Intercommunal de Creteil, Créteil, France, 10.Institut de Cancérologie de l'Ouest, Saint-Herblain Cedex, France, 11.Netherlands Cancer Institute and Leiden University Medical Center, Amsterdam, Netherlands, 12.University of Western Australia and Sir Charles Gairdner Hospital, Perth, Australia, 13.MD Anderson Cancer Center, Houston, TX, USA, 14.Mayo Clinic, Rochester, MN, USA, 15.Royal Marsden Hospital and Institute of Cancer Research, London, UK, 16.Bristol Myers Squibb, Princeton, NJ, USA, 17.Bichat-Claude Bernard University Hospital, AP-HP, Université de Paris, Paris, France)

^○Takashi Kijima¹, Terufumi Kato², Yasushi Goto³, Takashi Yokoi¹, Kozo Kuribayashi¹, Koji Mikami¹, Yasuko Fuchimoto⁴, Shuji Murakami², Tatsuya Yoshida³, Masae Homma⁵, Akira Wakana⁵, Kazuo Noguchi⁵, Nobukazu Fujimoto⁶ (1.Department of Respiratory Medicine and Hematology, Hyogo College of Medicine, 2.Department of Thoracic Oncology, Kanagawa Cancer Center, 3.Department of Thoracic Oncology, National Cancer Center Hospital, 4.Department of Respiratory Medicine, Okayama Rosai Hospital, 5.MSD K.K., Tokyo, Japan, 6.Department of Medical Oncology, Okayama Rosai Hospital)